(Q24685766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

W Kruis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

J Pokrotnieks

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

B Fixa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

M Kascák

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

M A Kamm

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

J Weismueller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

C Beglinger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

M Stolte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

C Wolff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

J Schulze

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

1617-1623

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

Saccharomyces boulardii in maintenance treatment of Crohn's disease

4 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Alternatives to Sulfasalazine: A Meta-analysis of 5-ASA in the Treatment of Ulcerative Colitis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Use of probiotics in the treatment of inflammatory bowel disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Bacteria as the cause of ulcerative colitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Probiotics and inflammatory bowel disease: is there a scientific rationale?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteria

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Salicylates for ulcerative colitis--their mode of action

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Microscopic activity in ulcerative colitis: what does it mean?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Enteric Microflora in IBD: Pathogens or Commensals?

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Properties of Escherichia coli strains of serotype O6.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

[Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor)]

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Re.: Oral administration of a certain strain of live Escherichia coli for intestinal disorders? (Infection 23 [1995] 51-54)

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774300

Probiotic therapy with E. coli for ulcerative colitis: take the good with the bad

28 November 2018

1 reference

12 December 2020

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

1 reference

12 December 2020

Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?

1 reference

12 December 2020

Diagnosis and therapy of ulcerative colitis--results of an evidence-based consensus conference of the German Society of Digestive and Metabolic Diseases

1 reference

12 December 2020

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

1 reference

12 December 2020

Specific Proliferative and Antibody Responses of Premature Infants to Intestinal Colonization with Nonpathogenic Probiotic E. coli Strain Nissle 1917

1 reference

12 December 2020

Induction and maintenance of remission with nonpathogenic Escherichia coli in patients with pouchitis

1 reference

12 December 2020

Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection

1 reference

12 December 2020

Postoperative recurrence of Crohn's disease: the enemy is within the fecal stream

1 reference

12 December 2020

[Probiotics for prevention of ulcerative colitis recurrence: alternative medicine added to standard treatment?]

1 reference

12 December 2020

A new measure of health status for clinical trials in inflammatory bowel disease

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.2003.037747

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

PubMed publication ID

15479682

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15479682%20AND%20SRC:MED&resulttype=core&format=json